European and UK qualified patent attorney specialising in the life sciences field. Experienced in co-ordinating patent strategies across the world including drafting, prosecution and third party issues. Main areas of interest include antibodies, nucleic acid technology, drug screening and simple medical devices.
BSc (Hons) Genetics (First Class), University of Nottingham, MSc Applied Biomolecular Technology (Distinction), University of Nottingham, European Patent Attorney, Chartered UK Patent Attorney.
2004-2008 - Research Scientist at AstraZeneca (Alderley Park, Cheshire). Working in cancer drug discovery, Tom undertook cellular and molecular research for early and mid-stage oncology projects and was heavily involved in the development of several drug screening strategies including both low-throughput and semi-automated high-throughput assays.
2003 - MSc industrial placement at Orchid Biosciences (Abingdon, Oxfordshire) working on the research and development of novel SNP genotyping assays.
Tom studied genetics (BSc (Hons)) at the University of Nottingham, followed by an MSc in applied biomolecular technology at the same university.
Subsequently, Tom spent four years as a research scientist in oncology bioscience at AstraZeneca before joining Potter Clarkson in 2009 where he now specialises in patents in the life sciences field.
Tom has particular experience of obtaining patent protection in antibody technology and therapeutics, nucleic acid technology, drug screening and simple medical devices. He has also been involved in several patent oppositions in the same subject areas.
Tom qualified as a European Patent Attorney in 2012 and a Chartered UK Patent Attorney in 2013.
In 2011, he was awarded the Nick Wilson Memorial Award for obtaining the highest mark overall in one of the UK qualifying exams.
Outside of the office, Tom has been actively involved in the Biotechnology YES competitions, acting as a judge or an IP mentor to students for the last five years.
Potter Clarkson has been at the forefront of intellectual property (IP) in Europe for over a century and is...
Jane Wainwright and Tom Harding write for the Life Sciences Intellectual Property Review.
Jane Wainwright and Tom Harding provide insight into the key Issues in building a strong life sciences patent portfolio.
Potter Clarkson is delighted to announce that it has promoted a number of their employees with effect from 1 January....
The European Patent Office (EPO), along with the patent offices of Japan, Korea, China and the United States...
Potter Clarkson LLP is proud to be sponsoring the Innovation Award at Medilink's Innovation Day on 13 June. Details...
Thursday 13 June, The Radisson Blu Hotel, East Midlands AirportPotter Clarkson LLP are again sponsoring the...
Potter Clarkson is pleased to announce the promotion of Craig Brownlie, David Carling, Joanna Deas, Mark Graham, Tom...